NanoBiotech Pharma, Inc
www.nanobiotechpharma.comNanoBiotech Pharma is a Pioneering & Revolutionary Life Science Company that develops products to address unmet health needs. Our published research shows that our novel approaches are uniquely effective. We are dedicated to our discoveries and development of novel compounds for Cardiology, Urology, Neurology, Pathology and other areas. Our pre-clinical science and clinical research is published and well-established. We now conduct research collaboratively at major institutions. Our flagship nanobiotic product, NanobacTX is designed to structurally address cardiovascular health and functionally improve heart health status. NanobacTX is a Patented non-prescription compound shown in published clinical trials by cardiologists and radiologists to regress calcified plaque volume as measured by decreased Coronary Artery Calcification (CAC) scores, improve lipid profiles and to increase individual exercise tolerance. Objective measurement parameters are markedly improving toward cardiovascular health. NanobacTX and Urobac are globally-patented non-prescription nutraceuticals. They are available for purchase online at http://www.NanoBiotechPharma.com as well as from participating physicians and pharmacies. Get started and improve your cardiovascular health! EMail us at info@NanoBiotechPharma.com
Read moreNanoBiotech Pharma is a Pioneering & Revolutionary Life Science Company that develops products to address unmet health needs. Our published research shows that our novel approaches are uniquely effective. We are dedicated to our discoveries and development of novel compounds for Cardiology, Urology, Neurology, Pathology and other areas. Our pre-clinical science and clinical research is published and well-established. We now conduct research collaboratively at major institutions. Our flagship nanobiotic product, NanobacTX is designed to structurally address cardiovascular health and functionally improve heart health status. NanobacTX is a Patented non-prescription compound shown in published clinical trials by cardiologists and radiologists to regress calcified plaque volume as measured by decreased Coronary Artery Calcification (CAC) scores, improve lipid profiles and to increase individual exercise tolerance. Objective measurement parameters are markedly improving toward cardiovascular health. NanobacTX and Urobac are globally-patented non-prescription nutraceuticals. They are available for purchase online at http://www.NanoBiotechPharma.com as well as from participating physicians and pharmacies. Get started and improve your cardiovascular health! EMail us at info@NanoBiotechPharma.com
Read moreCountry
Industry
Employees
11-50
Founded
2004
Estimated Revenue
$1,000,000 to $5,000,000
Social
Employees statistics
View all employeesPotential Decision Makers
Chief Executive Officer , Founder , Medical Director - Nanobiotech Pharma
Email ****** @****.comPhone (***) ****-****Director
Email ****** @****.comPhone (***) ****-****